Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent Deferred RevenueCurrent LeasesFinished GoodsGoodwillGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityLong-Term InvestmentsNon-Current AssetsNon-Current DebtNotes PayablesOperating LeasesOther Accumulated ExpensesOther Non-Current LiabilitiesPayablesPreferred SharesPrepaid AssetsProperty, Plant & Equipment (Net)Raw MaterialsReceivablesRetained EarningsShareholder's EquityShort term DebtTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current Liabilities
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

INVO Fertility (IVF) Long-Term Investments (2020 - 2025)

INVO Fertility (IVF) has disclosed Long-Term Investments for 6 consecutive years, with $2.5 million as the latest value for Q3 2025.

  • Quarterly Long-Term Investments rose 219.61% to $2.5 million in Q3 2025 from the year-ago period, while the trailing twelve-month figure was $2.5 million through Sep 2025, up 219.61% year-over-year, with the annual reading at $740759.0 for FY2024, 19.15% down from the prior year.
  • Long-Term Investments for Q3 2025 was $2.5 million at INVO Fertility, up from $645944.0 in the prior quarter.
  • The five-year high for Long-Term Investments was $2.5 million in Q3 2025, with the low at $141267.0 in Q2 2021.
  • Average Long-Term Investments over 5 years is $1.0 million, with a median of $997725.0 recorded in 2023.
  • The sharpest move saw Long-Term Investments skyrocketed 1419.04% in 2021, then dropped 28.48% in 2024.
  • Over 5 years, Long-Term Investments stood at $1.5 million in 2021, then decreased by 16.92% to $1.2 million in 2022, then dropped by 25.98% to $916248.0 in 2023, then dropped by 19.15% to $740759.0 in 2024, then soared by 233.01% to $2.5 million in 2025.
  • According to Business Quant data, Long-Term Investments over the past three periods came in at $2.5 million, $645944.0, and $710855.0 for Q3 2025, Q2 2025, and Q1 2025 respectively.